FDA approves generic versions of antipsychotic drug Abilify

(Reuters) - The U.S. Food and Drug Administration said it approved the first copycat versions of Otsuka Pharmaceutical Co Ltd's antipsychotic drug, Abilify.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news